<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="38527">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01946022</url>
  </required_header>
  <id_info>
    <org_study_id>13-0120</org_study_id>
    <secondary_id>HCPA</secondary_id>
    <nct_id>NCT01946022</nct_id>
  </id_info>
  <brief_title>Evaluation of  Granulosa Cells Function  After IVF Protocols</brief_title>
  <official_title>In Vitro Evaluation of Luteinized Granulosa Cells After Being Submitted to in Vitro Fertilization Protocols With Gonadotropin-Releasing Hormone (GnRH) Agonist and GnRH Antagonist</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hospital de Clinicas de Porto Alegre</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hospital de Clinicas de Porto Alegre</source>
  <oversight_info>
    <authority>Brazil: Associação Fundo de Incentivo à Pesquisa</authority>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study is intended to evaluate ovarian cells after being submitted do different in vitro
      fertilization protocols. The investigators will analyze hormones secretion and intracellular
      mechanisms of these cells comparing the GnRH agonist protocol and the GnRH antagonist
      protocol.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>September 2013</start_date>
  <primary_completion_date type="Anticipated">October 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Basic Science</study_design>
  <primary_outcome>
    <measure>Evaluation of steroid secretion and enzyme expression in in vitro luteinized granulosa cells</measure>
    <time_frame>after 48h in media culture</time_frame>
    <safety_issue>No</safety_issue>
    <description>evaluation of granulosa cells hormone secretion and enzyme expression in media culture 48 hours after ovarian punction</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Number of retrieved oocytes</measure>
    <time_frame>After the ovarian punction</time_frame>
    <safety_issue>Yes</safety_issue>
    <description>Immediately after the ovarian punction the number of retrieved oocytes will be evaluated</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>number of embryos</measure>
    <time_frame>3 to 5 days after ovarian punction</time_frame>
    <safety_issue>Yes</safety_issue>
    <description>the embryologist will verify the number of embryos after 3 to 5 days from the ovarian punction</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Subgroup analyses comparing FSH versus HMG protocols</measure>
    <time_frame>after ovarian punction</time_frame>
    <safety_issue>No</safety_issue>
    <description>It will be verified the differences between the two types of gonadotrophins in ovarian stimulation regarding: units of gonadotrophins used, number of retrieved oocytes,number of embryos and embryo score</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">28</enrollment>
  <condition>Infertility</condition>
  <condition>In Vitro Fertilization Protocols</condition>
  <arm_group>
    <arm_group_label>GnRH Agonist</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>GnRH long agonist protocol of invitro fertilization</description>
  </arm_group>
  <arm_group>
    <arm_group_label>GnRH Antagonist</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>GnRH fixed antagonist protocol of in vitro fertilization</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>randomization between the two GnRH analogues (agonist and antagonist)</intervention_name>
    <arm_group_label>GnRH Agonist</arm_group_label>
    <arm_group_label>GnRH Antagonist</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patient age limit: 39 years

          -  Follicle Stimulating Hormone (FSH) &lt; 10 micrometer (mU) / Liter

          -  Antral follicular count &gt; 12

          -  Regular menses (25 to 35 days)

          -  More than 3 oocytes after ovarian punction

          -  Anti Mullerian between 1 e 3 ng/ml

        Exclusion Criteria:

          -  Patients submitted to intracytoplasmatic sperm injection (ICSI)

          -  Ovarian mass or cyst

          -  Clinical / endocrine pathologies
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>39 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Rita d Chapon</last_name>
    <phone>5192028288</phone>
    <email>rchapon@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Projeto Cegonha</name>
      <address>
        <city>Porto Alegre</city>
        <state>RS</state>
        <zip>90020160</zip>
        <country>Brazil</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rita d Chapon</last_name>
      <phone>5192028288</phone>
      <email>rchapon@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Rita Chapon</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Insemine</name>
      <address>
        <city>Porto Alegre</city>
        <state>RS</state>
        <zip>91330001</zip>
        <country>Brazil</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rita</last_name>
    </contact>
    <investigator>
      <last_name>Rita Chapon</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Brazil</country>
  </location_countries>
  <verification_date>November 2013</verification_date>
  <lastchanged_date>November 6, 2013</lastchanged_date>
  <firstreceived_date>August 2, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>infertility</keyword>
  <keyword>ovulation induction</keyword>
  <keyword>luteal phase</keyword>
  <keyword>granulosa cells function</keyword>
  <keyword>GnRH agonist and antagonist</keyword>
  <keyword>HMG</keyword>
  <keyword>FSHr</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Infertility</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
